Biote (BTMD) EPS (Weighted Average and Diluted) (2021 - 2026)

Biote's EPS (Weighted Average and Diluted) history runs 6 years deep, the most recent figure standing at $0.06 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) fell 83.78% year-over-year to $0.06; the TTM figure through Mar 2026 stood at $0.44 (down 26.67% YoY), while the FY2025 annual figure was $0.74, up 722.22% from the prior year.
• EPS (Weighted Average and Diluted) was $0.06 for Q1 2026 at Biote, roughly flat from $0.06 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.37 in Q1 2025 to a low of -$0.39 in Q1 2023.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.05 across 5 years, with a median of $0.1 in 2025.
• The sharpest annual moves came in 2025 and 2026: EPS (Weighted Average and Diluted) soared 408.33% in 2025, then plunged 83.78% in 2026.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.22 in 2022, then surged by 45.45% to $0.32 in 2023, then plunged by 65.62% to $0.11 in 2024, then tumbled by 45.45% to $0.06 in 2025, then gained by 0.0% to $0.06 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.06 (Q1 2026), $0.06 (Q4 2025), and $0.22 (Q3 2025), per Business Quant data.